The ebook provides advice for pharma companies researching serialization solutions for the next round of the Drug Supply Chain Security Act (DSCSA) requirements slated for 2017, the Falsified Medicines Directive in the E.U. or other country- or region-specific regulations.
It challenges readers to think about what other business benefits a serialization platform can provide by asking questions like: What if you could do more with serialization? What if you could check the compliance box and, at the same time, improve your business operations?
Interestingly, as pharma manufacturers and outsourced packaging and distribution companies race to meet regulatory deadlines, adopters of serialization and track-and-trace technologies have begun to realize benefits that reach far beyond simply meeting compliance. The ebook provides three tips for moving beyond compliance into the creation of a more intelligent supply chain.
By reading this ebook, you will be able to understand the importance of:
- Mining intelligence from your supply chain to gain valuable insights, not just connections
- Leveraging intuitive reporting for better business decision-making
- Optimizing a serialization solution with flexible options for control and customization
Challenges addressed:
Meeting compliance requirements is always a concern for companies in regulated industries. With the next round of pharma regulations looming on the horizon, finding the right serialization partner that can both meet and extend serialization value throughout an organization is critical.
Additionally, several one-size-fits-all integration platforms do not leverage GS1’s EPCIS standards, creating challenges for partner networks with disparate data standards.
| Have Your Say Rate this feature and give us your feedback in the comments section below |